Coronavirus
Johnson & Johnson Vaccine Manufacturer Fails FDA Inspection
The Food and Drug Administration (FDA) on Wednesday issued a report on multiple failures at a troubled Baltimore vaccine manufacturing plant making Johnson & Johnson COVID-19 vaccine doses.
The report found the plant from Emergent BioSolutions, which previously was revealed to have ruined up to 15 million doses of vaccine, was “not maintained in a clean and sanitary condition” and some “procedures to prevent cross-contamination are not followed.”
The FDA has ordered a pause on manufacturing at the plant while the problems are addressed.
